Neurogenic
Clinical-stage diagnostics company developing sensitive immunoassays to assist in the diagnosis of mental disorders
StartupNeurogenic is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 1995. Clinical-stage diagnostics company developing sensitive immunoassays to assist in the diagnosis of mental disorders. The company has 1-10 employees. Core technologies: Biologicals, Molecules.
The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StagePre-Funding
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQTel Aviv-Yafo
- DistrictCenter District
- Last RoundUndisclosed
1 article covered by sources including www.synabs.be.
What does Neurogenic do?
Neurogenic is a clinical-stage diagnostics company developing sensitive immunoassays to assist in the diagnosis of mental disorders. The company has established long-term collaborations with the Weizmann Institute of Science, Rehovot, the Department of Psychiatry, Faculty of Medicine, Tel Aviv University, Tel Aviv, the Beer Yaakov-Ness-Ziona Mental Health Center, Ness Ziona, the Geha Mental Health Center, Petach Tikva, and the Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Beilinson Campus, Rabin Medical Center, Petah Tikva, Israel to develop a straightforward, sensitive ELISA-based immunoassay to detect the autoimmune Platelet-Associated Antibodies (PAA) in the sera of adolescent and pediatric patients suffering from early-onset symptoms of schizophrenia. Neurogenic is now in the final stages of assay optimization. The company is continuing clinical field testing and validation of the assay.
What sector is Neurogenic in?
Neurogenic operates in Health Tech & Life Sciences, Medical Devices, Diagnostics Devices, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Laboratories.
Where is Neurogenic located?
Neurogenic is based in Ahad Ha'Am St 9, Tel Aviv-Yafo, Israel, Center District.